Tarrytown, NY; received FDA approval in Dec. 1999 as a contract manufacturer for an undisclosed intermediate for a marketed vaccine from Merck & Co. and was expected to receive $50 million from Merck over 6 years
Related product monographs:
No products with related organizations were found.
